产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 药品制剂 Salbutamol Sulf...

Salbutamol Sulfate Inhaler: Rapid Relief for Asthma and COPD

2025-06-18
 元/个
上海市

产品详情

Salbutamol Sulfate Inhaler: Rapid Relief for Asthma and COPD
呼吸系统制剂
Salbutamol Sulfate Inhaler,Bronchodilator,Asthma Relief,COPD Treatment,Respiratory Inhalation Aerosol
中国,北美洲,中/南美洲,西欧,大洋洲,亚洲,中东,非洲

产品描述


Mechanism of Action

Salbutamol sulfate inhalation aerosol is a selective β₂-adrenergic receptor agonist. Its primary mechanism involves binding to β₂-receptors located on bronchial smooth muscle cells. Activation of these receptors leads to increased production of cyclic adenosine monophosphate (cAMP), which subsequently reduces intracellular calcium levels. This results in the relaxation of smooth muscles and bronchodilation, thereby alleviating symptoms of bronchial spasms. Additionally, salbutamol inhibits the release of inflammatory mediators from mast cells and other sensitized cells, further reducing bronchial spasms.

Applications

Salbutamol sulfate inhalation aerosol is widely used in the treatment of respiratory conditions characterized by bronchial spasms. Its primary applications include:

  • Asthma: It provides rapid relief during acute asthma attacks and is also used to prevent exercise-induced asthma.
  • Chronic Obstructive Pulmonary Disease (COPD): It helps in managing bronchial spasms associated with COPD, improving respiratory function.
  • Other Respiratory Conditions: It is also used to treat bronchial spasms associated with chronic bronchitis and other respiratory diseases.

Future Prospects

The future outlook for salbutamol sulfate inhalation aerosol is promising due to its proven efficacy and safety profile. Ongoing research is exploring its potential in combination therapies for more effective management of respiratory diseases. Additionally, advancements in inhaler technology are aimed at improving drug delivery and patient compliance. The increasing prevalence of asthma and COPD, particularly in developing countries, is expected to drive the demand for this medication.

Dosage and Administration

Adults:

  • Relief of Acute Symptoms: The initial dose is 100-200 μg (1-2 puffs), which can be repeated every 4-8 hours as needed. The maximum recommended dose is 8 puffs within 24 hours.
  • Prevention of Symptoms: For exercise-induced asthma, 1-2 puffs should be taken 10-15 minutes before the activity.
  • Children:
  • Relief of Acute Symptoms: The recommended dose is 1 puff (100 μg), which can be increased to 2 puffs if necessary.
  • Prevention of Symptoms: Similar to adults, 1-2 puffs should be taken 10-15 minutes before exposure to allergens or exercise.
  • Special Populations:
  • Elderly Patients: The initial dose should be lower than that for adults and adjusted based on response.
  • Patients with Liver or Kidney Impairment: Dose adjustments may be necessary to prevent drug accumulation.
  • Instructions for Use:
  • The inhaler should be used orally. Patients should shake the canister well before use and prime the inhaler by releasing four test sprays into the air if it has not been used for more than two weeks.
  • The patient should exhale completely, place the mouthpiece in their mouth, and press the canister while inhaling deeply. After inhalation, the patient should hold their breath for about 10 seconds before exhaling.

Storage

Salbutamol sulfate inhalation aerosol should be stored at temperatures below 30°C (86°F), protected from light and extreme cold. The canister should not be punctured, broken, or burned, even if it appears empty. It is also important to keep the inhaler out of reach of children.

上海浦津林州制药有限公司
访问店铺
注册资本
联系人

公司简介

上海浦津林州制药有限公司,始建于1974年,其前身是林州市市属工业企业--安阳市化学制药厂, 2015年9月更名为“上海浦津林州制药有限公司” 公司位于风景秀丽的太行山东麓,举世闻名的人工天河——红旗渠畔,交通便利,通讯发达。公司占地面积5.5万m2,建筑面积1.9万m2,其中仓储面积3000 m2;厂区绿化面积16000 m2,硬化面积8000 m2。现有职工300余人,固定资产总值6418万元,主导产品主要有葡萄糖酸钙、硫酸镁、维生素C、肌苷等35个注射液品种,在市场上深受广大客户青睐,市场前景广阔。公司为了进一步扩大生产规模,提升产品档次,提高市场占有率,先后投资3.6亿余元,进行技术改造,现在拥有12条符合国家GMP标准的小容量注射剂全自动生产线,并于2014年5月通过国家食品药品监督管理局GMP认证;新建车间年设计生产能力12亿支,可实现产值3亿多元,利税5000余万元。 近年来,公司创新意识不断增强,始终把“技术创新,科技兴厂”作为公司发展的宗旨,企业发展空间大、前景广阔,愿各界同仁、有识之士携手并进,共谋美好未来。